UROGEN PHARMA LTD (URGN:NASDAQ)
$21.57 1.04 (5.0658%)
Analysed UROGEN PHARMA LTD (URGN:NASDAQ) News Sources
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
08-04-2026
yahoo.com
Why The UroGen Pharma (URGN) Investment Story Is Shifting As Analysts Hold Fair Value Steady
04-04-2026
yahoo.com
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
30-03-2026
yahoo.com
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?
23-03-2026
fool.com
How UroGen Pharma (URGN) Narrative Is Evolving Around Fair Value Risks And Opportunities
20-03-2026
yahoo.com
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet?
18-03-2026
fool.com
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names
18-03-2026
fool.com
This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish
18-03-2026
fool.com
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
13-03-2026
yahoo.com
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06-03-2026
yahoo.com
What is the current price of UROGEN PHARMA LTD (URGN:NASDAQ)?
The current price of UROGEN PHARMA LTD (URGN:NASDAQ) is $21.57.
UROGEN PHARMA LTD (URGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of UROGEN PHARMA LTD (URGN:NASDAQ) since the previous trading day is $1.04.
UROGEN PHARMA LTD (URGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of UROGEN PHARMA LTD (URGN:NASDAQ) since the previous trading day is 5.0658%.
What is the most recent average sentiment score for UROGEN PHARMA LTD (URGN:NASDAQ)?
The most recent average sentiment score for UROGEN PHARMA LTD (URGN:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for UROGEN PHARMA LTD (URGN:NASDAQ)?
The most recent sentiment for UROGEN PHARMA LTD (URGN:NASDAQ) is .
SEC-8K** Filing Available For UROGEN PHARMA LTD (URGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.